2005N-0345 Drug Approvals: Circumstances under which an active ingredient may be simultaneously marketed in both a prescription drug product and an over-the-counter drug product
FDA Comment Number : EC2160
Submitter : Dr. Orel Friedman Date & Time: 10/31/2005 06:10:17
Organization : Dr. Orel Friedman
Category : Federal Government
Issue Areas/Comments
I urge the immediate approval of the sale of "the morning after pill" by the FDA without a prescription or restrictions.